Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 151.88B | 6.23%135.51B | 2.27%565.36B | 7.08%145.94B | -1.24%127.56B | 11.18%552.83B | -2.17%143.6B | 13.41%143.76B | 11.82%136.3B | 26.91%129.16B |
| Cost of revenue | 93.98B | 15.11%80.33B | -0.51%334.6B | -1.68%89B | -9.14%69.79B | 12.39%336.31B | -10.30%82.93B | 8.84%86.06B | 21.60%90.52B | 44.17%76.81B |
| Gross profit | 57.9B | -4.49%55.18B | 6.58%230.76B | 24.40%56.95B | 10.35%57.77B | 9.36%216.51B | 11.68%60.68B | 20.98%57.7B | -3.53%45.78B | 7.95%52.35B |
| Operating expense | 34.01B | 3.03%32.76B | -2.03%136.78B | 4.97%35.35B | -15.84%31.8B | -9.30%139.61B | -18.17%34.1B | -19.45%34.05B | -10.55%33.68B | 16.87%37.78B |
| Operating profit | 23.89B | -13.69%22.42B | 22.21%93.98B | 78.47%21.6B | 78.23%25.98B | 74.59%76.9B | 110.01%26.58B | 336.43%23.65B | 23.46%12.1B | -9.88%14.57B |
| Net non-operating interest income (expenses) | 114M | 2,600.00%54M | -225.41%-602M | -84.91%-196M | 102.20%2M | 75.50%-185M | 181.65%89M | 62.07%-77M | 57.09%-106M | 53.57%-91M |
| Non-operating interest income | --270M | 34.36%348M | 1.13%893M | 5.65%187M | 47.16%259M | 68.83%883M | 58.04%354M | 74.26%176M | 101.14%177M | 60.00%176M |
| Non-operating interest expense | --156M | 14.40%294M | 39.98%1.5B | 35.34%383M | -3.75%257M | -16.43%1.07B | -20.42%265M | -16.78%253M | -15.52%283M | -12.75%267M |
| Net investment income | 3.17B | -175.71%-4.34B | -9.14%8.62B | -41.20%6.48B | 294.09%5.73B | 7.57%9.49B | 26.88%-5.07B | 4.15%2.08B | 25.11%11.02B | -70.60%1.45B |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 79M | -2.03%145M | -55.44%6.73B | 0 | 148M | -17.20%15.11B | 0 | 4.35%14.35B | 1,032.84%759M | 0 |
| Income from associates and other participating interests | 1M | 1,116.67%61M | 290.00%57M | 93.75%-1M | -220.00%-6M | -115.08%-30M | -89.16%9M | -157.14%-28M | -127.12%-16M | -37.50%5M |
| Special income (charges) | -289M | -56.72%174M | -43.36%-7.26B | 120.81%896M | 145.17%402M | -90.92%-5.07B | 173.68%501M | -337.65%-372M | -154.64%-4.31B | -349.49%-890M |
| Less:Other special charges | --159M | 56.30%-208M | -113.63%-411M | -133.07%-1.15B | -211.74%-476M | 57.25%3.02B | -461.34%-1.13B | 444.29%241M | 130.46%3.48B | 158.18%426M |
| Less:Write off | --130M | -54.05%34M | 274.21%7.68B | -69.13%255M | -84.05%74M | 178.67%2.05B | 71.66%630M | -15.48%131M | 356.35%826M | 1,306.06%464M |
| Other non-operating income (expenses) | -193M | -65.73%61M | 146.40%58M | 135.14%13M | 225.35%178M | 90.21%-125M | -181.13%-43M | 119.92%97M | 91.63%-37M | 64.59%-142M |
| Income before tax | 26.77B | -42.72%18.58B | 5.72%101.58B | 48.28%28.79B | 117.52%32.43B | 44.22%96.08B | 336.03%22.06B | 94.20%39.7B | 18.70%19.41B | -39.80%14.91B |
| Income tax | 7.04B | -45.90%5.07B | 12.03%26.77B | 745.27%9.84B | 124.89%9.37B | 28.02%23.9B | 246.30%6.51B | 79.84%12.06B | -62.68%1.16B | -40.16%4.17B |
| Net income | 19.73B | -41.43%13.51B | 3.64%74.81B | 3.83%18.95B | 114.65%23.06B | 50.53%72.19B | 389.09%15.55B | 101.20%27.64B | 37.89%18.25B | -39.66%10.74B |
| Net income continuous operations | --19.73B | -41.43%13.51B | 3.64%74.81B | 3.82%18.95B | 114.66%23.06B | 50.53%72.19B | 389.06%15.55B | 101.22%27.64B | 37.88%18.25B | -39.66%10.74B |
| Noncontrolling interests | 0 | 0 | -87M | 771.43%47M | -2M | 300.00%8M | -2,900.00%-140M | |||
| Net income attributable to the company | 19.73B | -41.43%13.51B | 3.51%74.81B | 3.88%18.95B | 111.87%23.06B | 50.71%72.27B | 386.36%15.51B | 101.24%27.65B | 37.83%18.24B | -38.85%10.88B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 19.73B | -41.43%13.51B | 3.51%74.81B | 3.88%18.95B | 111.87%23.06B | 50.71%72.27B | 386.36%15.51B | 101.24%27.65B | 37.83%18.24B | -38.85%10.88B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 128.1 | -41.43%87.709 | 3.50%485.86 | 3.87%123.05 | 111.85%149.76 | 50.69%469.42 | 386.29%100.71 | 101.20%179.55 | 37.85%118.47 | -38.86%70.69 |
| Diluted earnings per share | 128.0997 | -41.43%87.709 | 3.50%485.86 | 3.87%123.05 | 111.85%149.76 | 50.69%469.42 | 386.26%100.7025 | 101.20%179.55 | 37.85%118.47 | -38.86%70.69 |
| Dividend per share | 0 | 0 | 20.00%120 | 150.00%50 | 0 | 25.00%100 | 60.00%80 | 0 | -33.33%20 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |